Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.96588015 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.90938059 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.90938059 |
4 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.85171375 |
5 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.80307766 |
6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.50408687 |
7 | barbed-end actin filament capping (GO:0051016) | 4.40553144 |
8 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.21617354 |
9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.06287013 |
10 | GDP-mannose metabolic process (GO:0019673) | 3.81231148 |
11 | heme biosynthetic process (GO:0006783) | 3.79972343 |
12 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.79688446 |
13 | positive regulation of B cell differentiation (GO:0045579) | 3.77280160 |
14 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.59630136 |
15 | oxygen transport (GO:0015671) | 3.52776924 |
16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.51262675 |
17 | myeloid dendritic cell differentiation (GO:0043011) | 3.48606763 |
18 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.46252797 |
19 | defense response to protozoan (GO:0042832) | 3.44148722 |
20 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.42703722 |
21 | myeloid dendritic cell activation (GO:0001773) | 3.42548525 |
22 | DNA deamination (GO:0045006) | 3.41860036 |
23 | Golgi transport vesicle coating (GO:0048200) | 3.41748160 |
24 | COPI coating of Golgi vesicle (GO:0048205) | 3.41748160 |
25 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.41277739 |
26 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.37070411 |
27 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.36447175 |
28 | negative regulation of phagocytosis (GO:0050765) | 3.35656430 |
29 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.35409997 |
30 | ribosomal small subunit assembly (GO:0000028) | 3.26984003 |
31 | response to protozoan (GO:0001562) | 3.25365477 |
32 | immunoglobulin mediated immune response (GO:0016064) | 3.24910954 |
33 | hemoglobin metabolic process (GO:0020027) | 3.24495379 |
34 | protein localization to endosome (GO:0036010) | 3.24229331 |
35 | regulation of gamma-delta T cell activation (GO:0046643) | 3.23893290 |
36 | positive regulation by symbiont of host defense response (GO:0052509) | 3.20335084 |
37 | modulation by symbiont of host defense response (GO:0052031) | 3.20335084 |
38 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.20335084 |
39 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.20335084 |
40 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.20335084 |
41 | modulation by symbiont of host immune response (GO:0052553) | 3.20335084 |
42 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.20007749 |
43 | response to host (GO:0075136) | 3.20007749 |
44 | response to host defenses (GO:0052200) | 3.20007749 |
45 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.18450591 |
46 | modulation by virus of host process (GO:0019054) | 3.14642543 |
47 | NIK/NF-kappaB signaling (GO:0038061) | 3.13578319 |
48 | positive regulation of interferon-alpha production (GO:0032727) | 3.12620565 |
49 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.11083001 |
50 | heme metabolic process (GO:0042168) | 3.10215327 |
51 | modulation by symbiont of host cellular process (GO:0044068) | 3.08961401 |
52 | regulation of B cell differentiation (GO:0045577) | 3.08643692 |
53 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.04860118 |
54 | proline biosynthetic process (GO:0006561) | 3.03501955 |
55 | regulation of interferon-alpha production (GO:0032647) | 3.03198233 |
56 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.02722304 |
57 | response to host immune response (GO:0052572) | 3.02722304 |
58 | negative regulation of interleukin-12 production (GO:0032695) | 3.00892945 |
59 | cellular response to arsenic-containing substance (GO:0071243) | 2.98713585 |
60 | pentose-phosphate shunt (GO:0006098) | 2.97905490 |
61 | B cell receptor signaling pathway (GO:0050853) | 2.94532624 |
62 | mannose metabolic process (GO:0006013) | 2.94019922 |
63 | negative regulation of necroptotic process (GO:0060546) | 2.91778372 |
64 | tetrapyrrole biosynthetic process (GO:0033014) | 2.87425937 |
65 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.87076142 |
66 | dendritic cell differentiation (GO:0097028) | 2.86969251 |
67 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.86900799 |
68 | porphyrin-containing compound metabolic process (GO:0006778) | 2.85973151 |
69 | gas transport (GO:0015669) | 2.85919213 |
70 | protein maturation by protein folding (GO:0022417) | 2.85838115 |
71 | mitochondrial calcium ion transport (GO:0006851) | 2.85540793 |
72 | type I interferon signaling pathway (GO:0060337) | 2.84192693 |
73 | cellular response to type I interferon (GO:0071357) | 2.84192693 |
74 | macrophage activation involved in immune response (GO:0002281) | 2.82459189 |
75 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.81577415 |
76 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.80045824 |
77 | response to type I interferon (GO:0034340) | 2.79915549 |
78 | neutrophil mediated immunity (GO:0002446) | 2.79615140 |
79 | respiratory burst (GO:0045730) | 2.78139022 |
80 | negative regulation of granulocyte differentiation (GO:0030853) | 2.77431788 |
81 | apoptotic process involved in morphogenesis (GO:0060561) | 2.76416558 |
82 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.75508621 |
83 | cellular response to zinc ion (GO:0071294) | 2.72415922 |
84 | glycosphingolipid catabolic process (GO:0046479) | 2.71561939 |
85 | response to peptidoglycan (GO:0032494) | 2.70584167 |
86 | amyloid precursor protein catabolic process (GO:0042987) | 2.69429969 |
87 | neutrophil activation involved in immune response (GO:0002283) | 2.69257473 |
88 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.67777873 |
89 | cellular response to virus (GO:0098586) | 2.67735290 |
90 | response to muramyl dipeptide (GO:0032495) | 2.67680572 |
91 | cellular response to interferon-beta (GO:0035458) | 2.66696135 |
92 | IMP biosynthetic process (GO:0006188) | 2.65326392 |
93 | amino sugar catabolic process (GO:0046348) | 2.65133016 |
94 | positive regulation of antigen processing and presentation (GO:0002579) | 2.64174926 |
95 | positive regulation of isotype switching (GO:0045830) | 2.63968014 |
96 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.63067615 |
97 | regulation of response to osmotic stress (GO:0047484) | 2.60450913 |
98 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.59924909 |
99 | actin nucleation (GO:0045010) | 2.58804001 |
100 | mast cell activation (GO:0045576) | 2.57947007 |
101 | B cell mediated immunity (GO:0019724) | 2.56680924 |
102 | pentose metabolic process (GO:0019321) | 2.56495387 |
103 | mitochondrial fusion (GO:0008053) | 2.56114064 |
104 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.54947519 |
105 | T cell homeostasis (GO:0043029) | 2.54649475 |
106 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.53693767 |
107 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.52014788 |
108 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.50272444 |
109 | positive regulation of interferon-beta production (GO:0032728) | 2.49962009 |
110 | NADPH regeneration (GO:0006740) | 2.49033866 |
111 | pyrimidine-containing compound salvage (GO:0008655) | 2.48115605 |
112 | pyrimidine nucleoside salvage (GO:0043097) | 2.48115605 |
113 | leukocyte aggregation (GO:0070486) | 2.47780141 |
114 | glycolipid catabolic process (GO:0019377) | 2.47559612 |
115 | regulation of mast cell degranulation (GO:0043304) | 2.46635202 |
116 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.45974742 |
117 | detection of bacterium (GO:0016045) | 2.45292613 |
118 | IMP metabolic process (GO:0046040) | 2.45260853 |
119 | regulation of response to interferon-gamma (GO:0060330) | 2.44972513 |
120 | protein retention in ER lumen (GO:0006621) | 2.44609664 |
121 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.43751741 |
122 | sodium ion export (GO:0071436) | 2.42767521 |
123 | oligosaccharide catabolic process (GO:0009313) | 2.42384565 |
124 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.42292289 |
125 | regulation of protein heterodimerization activity (GO:0043497) | 2.42004805 |
126 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.41738459 |
127 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.41602330 |
128 | myeloid leukocyte mediated immunity (GO:0002444) | 2.41436205 |
129 | positive regulation of B cell mediated immunity (GO:0002714) | 2.41267770 |
130 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.41267770 |
131 | response to interleukin-15 (GO:0070672) | 2.40903357 |
132 | positive regulation of fibroblast migration (GO:0010763) | 2.40328515 |
133 | response to interferon-alpha (GO:0035455) | 2.39904084 |
134 | germinal center formation (GO:0002467) | 2.39541361 |
135 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.38448093 |
136 | regulation of growth of symbiont in host (GO:0044126) | 2.38448093 |
137 | negative regulation of growth of symbiont in host (GO:0044130) | 2.38448093 |
138 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.38448093 |
139 | regulation of necroptotic process (GO:0060544) | 2.37554990 |
140 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.37303490 |
141 | pinocytosis (GO:0006907) | 2.37080183 |
142 | negative regulation of viral release from host cell (GO:1902187) | 2.36891118 |
143 | T cell migration (GO:0072678) | 2.36777613 |
144 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.36345533 |
145 | endosome to melanosome transport (GO:0035646) | 2.36143319 |
146 | endosome to pigment granule transport (GO:0043485) | 2.36143319 |
147 | myeloid cell activation involved in immune response (GO:0002275) | 2.35976826 |
148 | response to interferon-beta (GO:0035456) | 2.35799986 |
149 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.35156385 |
150 | regulation of necrotic cell death (GO:0010939) | 2.35042788 |
151 | glucose catabolic process (GO:0006007) | 2.34894006 |
152 | detection of other organism (GO:0098543) | 2.34556280 |
153 | positive regulation of extracellular matrix organization (GO:1903055) | 2.34171947 |
154 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.33386700 |
155 | regulation of actin cytoskeleton reorganization (GO:2000249) | 2.33208426 |
156 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.33007330 |
157 | T cell apoptotic process (GO:0070231) | 2.32702319 |
158 | cellular response to interferon-gamma (GO:0071346) | 2.32607255 |
159 | UV protection (GO:0009650) | 2.32225195 |
160 | lymphocyte homeostasis (GO:0002260) | 2.32212354 |
161 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.31783863 |
162 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.31700198 |
163 | negative regulation of cell killing (GO:0031342) | 2.31700198 |
164 | positive regulation of protein homooligomerization (GO:0032464) | 2.31622576 |
165 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.31173741 |
166 | stress fiber assembly (GO:0043149) | 2.30886481 |
167 | regulation of superoxide anion generation (GO:0032928) | 2.30750555 |
168 | regulation of early endosome to late endosome transport (GO:2000641) | 2.29624586 |
169 | glucose 6-phosphate metabolic process (GO:0051156) | 2.28929427 |
170 | erythrocyte maturation (GO:0043249) | 2.28049377 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.47848360 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.74193219 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.52321577 |
4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.39141315 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.36591374 |
6 | MYC_22102868_ChIP-Seq_BL_Human | 3.12878069 |
7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.09647120 |
8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.99572365 |
9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.74935716 |
10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.74712996 |
11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.72693638 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.69510093 |
13 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.62985889 |
14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.55845238 |
15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.54854723 |
16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.37598777 |
17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27146530 |
18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.25799383 |
19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.24668414 |
20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.23458456 |
21 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.23308846 |
22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.19569074 |
23 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19479917 |
24 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.18322928 |
25 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.16449018 |
26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11161919 |
27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.08756739 |
28 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08671489 |
29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.06082539 |
30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.04482280 |
31 | MAF_26560356_Chip-Seq_TH1_Human | 1.97660456 |
32 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93218075 |
33 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.82282186 |
34 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.79101394 |
35 | MYB_26560356_Chip-Seq_TH2_Human | 1.78041333 |
36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.75876430 |
37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.75602787 |
38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.74898984 |
39 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.74046586 |
40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.73439013 |
41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.72321660 |
42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.71395613 |
43 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.70275109 |
44 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.70010105 |
45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.69540573 |
46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.68333795 |
47 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.66292904 |
48 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.66045513 |
49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.64565683 |
50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63360487 |
51 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.61907004 |
52 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.61658638 |
53 | MYB_26560356_Chip-Seq_TH1_Human | 1.60763146 |
54 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.60443195 |
55 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.59411091 |
56 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.54662315 |
57 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.53957173 |
58 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.51052321 |
59 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.50320457 |
60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.48938907 |
61 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.44709007 |
62 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.44535367 |
63 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.42858194 |
64 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.41840421 |
65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40953431 |
66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.40935493 |
67 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.40455861 |
68 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39680973 |
69 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.39633515 |
70 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.39606132 |
71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.39267151 |
72 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.39169579 |
73 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.37333511 |
74 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.36939549 |
75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.35065353 |
76 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.34406798 |
77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33766109 |
78 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32934934 |
79 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.31866666 |
80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31664312 |
81 | MAF_26560356_Chip-Seq_TH2_Human | 1.31317639 |
82 | P68_20966046_ChIP-Seq_HELA_Human | 1.31155504 |
83 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.29534933 |
84 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28118211 |
85 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.27009467 |
86 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.26991930 |
87 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.25206136 |
88 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.24712135 |
89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.24456338 |
90 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.24413426 |
91 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23821049 |
92 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22825791 |
93 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.20953303 |
94 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.20209557 |
95 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.19643149 |
96 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18227021 |
97 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17801859 |
98 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17346574 |
99 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.17307632 |
100 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.17009258 |
101 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.16481172 |
102 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.15052582 |
103 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14775601 |
104 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.13855236 |
105 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.13488051 |
106 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13414277 |
107 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.13410153 |
108 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.12617804 |
109 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12076595 |
110 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.12024704 |
111 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.11886675 |
112 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11726986 |
113 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10289166 |
114 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.10216068 |
115 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09893745 |
116 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09788007 |
117 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.09749174 |
118 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09119489 |
119 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08996697 |
120 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.08664811 |
121 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07335448 |
122 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06848793 |
123 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.06583901 |
124 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06022151 |
125 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.05541734 |
126 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.04237755 |
127 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.03397050 |
128 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02966107 |
129 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02869919 |
130 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02243359 |
131 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02121588 |
132 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01478925 |
133 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.99951332 |
134 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99915803 |
135 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99575651 |
136 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99256893 |
137 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96698034 |
138 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94289849 |
139 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.93904263 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.81316774 |
2 | MP0005451_abnormal_body_composition | 3.48340489 |
3 | MP0003303_peritoneal_inflammation | 3.17680010 |
4 | MP0005671_abnormal_response_to | 3.16504731 |
5 | MP0002396_abnormal_hematopoietic_system | 2.80824598 |
6 | MP0003656_abnormal_erythrocyte_physiolo | 2.77714762 |
7 | MP0003436_decreased_susceptibility_to | 2.75978836 |
8 | MP0003705_abnormal_hypodermis_morpholog | 2.62052049 |
9 | MP0001800_abnormal_humoral_immune | 2.50572914 |
10 | MP0002452_abnormal_antigen_presenting | 2.43423582 |
11 | MP0005000_abnormal_immune_tolerance | 2.42758962 |
12 | MP0009785_altered_susceptibility_to | 2.41904202 |
13 | MP0008260_abnormal_autophagy | 2.41350533 |
14 | MP0000685_abnormal_immune_system | 2.37247319 |
15 | MP0004510_myositis | 2.36072556 |
16 | MP0003763_abnormal_thymus_physiology | 2.35466846 |
17 | MP0002148_abnormal_hypersensitivity_rea | 2.33367477 |
18 | MP0009333_abnormal_splenocyte_physiolog | 2.31793238 |
19 | MP0002419_abnormal_innate_immunity | 2.30080791 |
20 | MP0002723_abnormal_immune_serum | 2.29455053 |
21 | MP0002420_abnormal_adaptive_immunity | 2.28242055 |
22 | MP0001819_abnormal_immune_cell | 2.26371677 |
23 | MP0005025_abnormal_response_to | 2.25062308 |
24 | MP0008438_abnormal_cutaneous_collagen | 2.22007320 |
25 | MP0003172_abnormal_lysosome_physiology | 2.21331791 |
26 | MP0005464_abnormal_platelet_physiology | 2.17255401 |
27 | MP0005387_immune_system_phenotype | 2.16351562 |
28 | MP0001790_abnormal_immune_system | 2.16351562 |
29 | MP0002398_abnormal_bone_marrow | 2.09713563 |
30 | MP0005058_abnormal_lysosome_morphology | 2.05992346 |
31 | MP0002405_respiratory_system_inflammati | 2.05215354 |
32 | MP0006082_CNS_inflammation | 1.98074734 |
33 | MP0001873_stomach_inflammation | 1.95515906 |
34 | MP0004782_abnormal_surfactant_physiolog | 1.87408410 |
35 | MP0001853_heart_inflammation | 1.86689156 |
36 | MP0000716_abnormal_immune_system | 1.86345150 |
37 | MP0003950_abnormal_plasma_membrane | 1.85468041 |
38 | MP0004808_abnormal_hematopoietic_stem | 1.82012842 |
39 | MP0003300_gastrointestinal_ulcer | 1.81863029 |
40 | MP0000689_abnormal_spleen_morphology | 1.81808069 |
41 | MP0002722_abnormal_immune_system | 1.75933721 |
42 | MP0002166_altered_tumor_susceptibility | 1.71785950 |
43 | MP0003566_abnormal_cell_adhesion | 1.68966943 |
44 | MP0002429_abnormal_blood_cell | 1.68072202 |
45 | MP0002877_abnormal_melanocyte_morpholog | 1.66913829 |
46 | MP0005083_abnormal_biliary_tract | 1.66358634 |
47 | MP0008007_abnormal_cellular_replicative | 1.64790514 |
48 | MP0001545_abnormal_hematopoietic_system | 1.60492972 |
49 | MP0005397_hematopoietic_system_phenotyp | 1.60492972 |
50 | MP0003279_aneurysm | 1.57767340 |
51 | MP0003724_increased_susceptibility_to | 1.54816789 |
52 | MP0000703_abnormal_thymus_morphology | 1.52028795 |
53 | MP0003866_abnormal_defecation | 1.50946096 |
54 | MP0000858_altered_metastatic_potential | 1.50547755 |
55 | MP0000465_gastrointestinal_hemorrhage | 1.50152395 |
56 | MP0004084_abnormal_cardiac_muscle | 1.49829709 |
57 | MP0001845_abnormal_inflammatory_respons | 1.46297514 |
58 | MP0010155_abnormal_intestine_physiology | 1.44086524 |
59 | MP0001533_abnormal_skeleton_physiology | 1.42950530 |
60 | MP0000490_abnormal_crypts_of | 1.41807624 |
61 | MP0003693_abnormal_embryo_hatching | 1.40000613 |
62 | MP0010352_gastrointestinal_tract_polyps | 1.38685790 |
63 | MP0009840_abnormal_foam_cell | 1.37517211 |
64 | MP0002006_tumorigenesis | 1.36147211 |
65 | MP0001849_ear_inflammation | 1.34794417 |
66 | MP0003453_abnormal_keratinocyte_physiol | 1.29376047 |
67 | MP0002132_abnormal_respiratory_system | 1.28205545 |
68 | MP0003075_altered_response_to | 1.26254213 |
69 | MP0003806_abnormal_nucleotide_metabolis | 1.25291121 |
70 | MP0003448_altered_tumor_morphology | 1.24395369 |
71 | MP0006054_spinal_hemorrhage | 1.21844478 |
72 | MP0000678_abnormal_parathyroid_gland | 1.21425687 |
73 | MP0003091_abnormal_cell_migration | 1.20339701 |
74 | MP0010307_abnormal_tumor_latency | 1.18144669 |
75 | MP0004147_increased_porphyrin_level | 1.11224543 |
76 | MP0005501_abnormal_skin_physiology | 1.11119298 |
77 | MP0001661_extended_life_span | 1.10478838 |
78 | MP0008469_abnormal_protein_level | 1.09839512 |
79 | MP0000343_altered_response_to | 1.08713187 |
80 | MP0002933_joint_inflammation | 1.08627939 |
81 | MP0003186_abnormal_redox_activity | 1.07703047 |
82 | MP0004947_skin_inflammation | 1.06920909 |
83 | MP0005076_abnormal_cell_differentiation | 1.04318705 |
84 | MP0004185_abnormal_adipocyte_glucose | 1.01433247 |
85 | MP0003077_abnormal_cell_cycle | 1.01376272 |
86 | MP0009278_abnormal_bone_marrow | 1.00115368 |
87 | MP0002090_abnormal_vision | 0.99541289 |
88 | MP0003111_abnormal_nucleus_morphology | 0.95871494 |
89 | MP0008057_abnormal_DNA_replication | 0.95339526 |
90 | MP0002019_abnormal_tumor_incidence | 0.91535916 |
91 | MP0002998_abnormal_bone_remodeling | 0.91065148 |
92 | MP0000733_abnormal_muscle_development | 0.90958134 |
93 | MP0003828_pulmonary_edema | 0.89278000 |
94 | MP0004233_abnormal_muscle_weight | 0.87654188 |
95 | MP0005165_increased_susceptibility_to | 0.87089180 |
96 | MP0003221_abnormal_cardiomyocyte_apopto | 0.86784203 |
97 | MP0000313_abnormal_cell_death | 0.85427726 |
98 | MP0009931_abnormal_skin_appearance | 0.85062502 |
99 | MP0000767_abnormal_smooth_muscle | 0.84685807 |
100 | MP0000604_amyloidosis | 0.84109875 |
101 | MP0005621_abnormal_cell_physiology | 0.81790952 |
102 | MP0000759_abnormal_skeletal_muscle | 0.80995974 |
103 | MP0001851_eye_inflammation | 0.80925578 |
104 | MP0006036_abnormal_mitochondrial_physio | 0.79916712 |
105 | MP0003191_abnormal_cellular_cholesterol | 0.79597412 |
106 | MP0005166_decreased_susceptibility_to | 0.78783967 |
107 | MP0001958_emphysema | 0.78746364 |
108 | MP0010094_abnormal_chromosome_stability | 0.77484039 |
109 | MP0005330_cardiomyopathy | 0.77181092 |
110 | MP0000750_abnormal_muscle_regeneration | 0.76487295 |
111 | MP0004858_abnormal_nervous_system | 0.76338771 |
112 | MP0001663_abnormal_digestive_system | 0.74914623 |
113 | MP0008874_decreased_physiological_sensi | 0.74659885 |
114 | MP0005310_abnormal_salivary_gland | 0.74141595 |
115 | MP0004145_abnormal_muscle_electrophysio | 0.73091030 |
116 | MP0005623_abnormal_meninges_morphology | 0.71798985 |
117 | MP0009764_decreased_sensitivity_to | 0.70891229 |
118 | MP0001348_abnormal_lacrimal_gland | 0.70418939 |
119 | MP0000749_muscle_degeneration | 0.70171844 |
120 | MP0001730_embryonic_growth_arrest | 0.69154732 |
121 | MP0003786_premature_aging | 0.69024969 |
122 | MP0004036_abnormal_muscle_relaxation | 0.67437453 |
123 | MP0004957_abnormal_blastocyst_morpholog | 0.67017273 |
124 | MP0008058_abnormal_DNA_repair | 0.65850458 |
125 | MP0003795_abnormal_bone_structure | 0.65444554 |
126 | MP0000015_abnormal_ear_pigmentation | 0.65407239 |
127 | MP0004215_abnormal_myocardial_fiber | 0.65053977 |
128 | MP0000358_abnormal_cell_content/ | 0.63808532 |
129 | MP0005023_abnormal_wound_healing | 0.63215060 |
130 | MP0000249_abnormal_blood_vessel | 0.62812260 |
131 | MP0002089_abnormal_postnatal_growth/wei | 0.62155224 |
132 | MP0000350_abnormal_cell_proliferation | 0.61696651 |
133 | MP0008775_abnormal_heart_ventricle | 0.58234053 |
134 | MP0003943_abnormal_hepatobiliary_system | 0.57872294 |
135 | MP0002083_premature_death | 0.56820227 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.36210689 |
2 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.01372685 |
3 | Eczematoid dermatitis (HP:0000976) | 3.99854156 |
4 | Recurrent abscess formation (HP:0002722) | 3.97827159 |
5 | Increased cerebral lipofuscin (HP:0011813) | 3.57678383 |
6 | Recurrent bacterial skin infections (HP:0005406) | 3.39801913 |
7 | Thrombocytosis (HP:0001894) | 3.38311901 |
8 | Myositis (HP:0100614) | 3.37440943 |
9 | Congenital stationary night blindness (HP:0007642) | 3.36487631 |
10 | Chronic otitis media (HP:0000389) | 3.35488586 |
11 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.26906113 |
12 | Recurrent viral infections (HP:0004429) | 3.23758834 |
13 | Ileus (HP:0002595) | 3.23217555 |
14 | Cholelithiasis (HP:0001081) | 3.19887219 |
15 | Vertebral compression fractures (HP:0002953) | 3.19610086 |
16 | Hypochromic microcytic anemia (HP:0004840) | 3.18177751 |
17 | Mediastinal lymphadenopathy (HP:0100721) | 3.18116209 |
18 | Recurrent fungal infections (HP:0002841) | 3.16210671 |
19 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.11731717 |
20 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.11731717 |
21 | Abnormality of glycolipid metabolism (HP:0010969) | 3.11731717 |
22 | Polycythemia (HP:0001901) | 3.08954350 |
23 | Abnormality of macrophages (HP:0004311) | 3.07979077 |
24 | Hypertensive crisis (HP:0100735) | 3.05251164 |
25 | IgM deficiency (HP:0002850) | 2.98673519 |
26 | Abnormal gallbladder physiology (HP:0012438) | 2.91891471 |
27 | Cholecystitis (HP:0001082) | 2.91891471 |
28 | Panhypogammaglobulinemia (HP:0003139) | 2.91054377 |
29 | Interstitial pulmonary disease (HP:0006530) | 2.90929487 |
30 | Dysostosis multiplex (HP:0000943) | 2.82196010 |
31 | Abnormal gallbladder morphology (HP:0012437) | 2.72430657 |
32 | Agammaglobulinemia (HP:0004432) | 2.72297841 |
33 | Reticulocytosis (HP:0001923) | 2.71940783 |
34 | Albinism (HP:0001022) | 2.71909541 |
35 | Obstructive lung disease (HP:0006536) | 2.67343700 |
36 | Chronic obstructive pulmonary disease (HP:0006510) | 2.67343700 |
37 | Vacuolated lymphocytes (HP:0001922) | 2.64118691 |
38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.59036684 |
39 | Basal ganglia calcification (HP:0002135) | 2.55669874 |
40 | Abnormality of T cell physiology (HP:0011840) | 2.54142284 |
41 | Fatigue (HP:0012378) | 2.53590430 |
42 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.52791728 |
43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.52791728 |
44 | Cellulitis (HP:0100658) | 2.52108345 |
45 | Hypochromic anemia (HP:0001931) | 2.50706694 |
46 | Petechiae (HP:0000967) | 2.46512905 |
47 | Gastrointestinal inflammation (HP:0004386) | 2.42138265 |
48 | Abnormality of the sella turcica (HP:0002679) | 2.42109658 |
49 | Chest pain (HP:0100749) | 2.39008568 |
50 | Urticaria (HP:0001025) | 2.38549206 |
51 | J-shaped sella turcica (HP:0002680) | 2.37654059 |
52 | Microcytic anemia (HP:0001935) | 2.36552590 |
53 | Spontaneous hematomas (HP:0007420) | 2.35974464 |
54 | Abnormality of the gallbladder (HP:0005264) | 2.34693302 |
55 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.34544476 |
56 | Recurrent bronchitis (HP:0002837) | 2.34437701 |
57 | Recurrent skin infections (HP:0001581) | 2.33144065 |
58 | Joint stiffness (HP:0001387) | 2.32899207 |
59 | Inflammation of the large intestine (HP:0002037) | 2.31527703 |
60 | Protrusio acetabuli (HP:0003179) | 2.31326995 |
61 | Loss of speech (HP:0002371) | 2.31066374 |
62 | Colitis (HP:0002583) | 2.29997839 |
63 | Abnormal platelet function (HP:0011869) | 2.29006752 |
64 | Impaired platelet aggregation (HP:0003540) | 2.29006752 |
65 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.29006082 |
66 | Entropion (HP:0000621) | 2.27800525 |
67 | Poikiloderma (HP:0001029) | 2.26664408 |
68 | Distal lower limb muscle weakness (HP:0009053) | 2.26579777 |
69 | Gastrointestinal dysmotility (HP:0002579) | 2.25701119 |
70 | Abnormality of T cells (HP:0002843) | 2.25481555 |
71 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.23131320 |
72 | Ragged-red muscle fibers (HP:0003200) | 2.22920461 |
73 | Granulocytopenia (HP:0001913) | 2.22868145 |
74 | Meningitis (HP:0001287) | 2.22735075 |
75 | Spinal rigidity (HP:0003306) | 2.22497559 |
76 | Stomatitis (HP:0010280) | 2.22356372 |
77 | Gastrointestinal infarctions (HP:0005244) | 2.20853756 |
78 | Poor head control (HP:0002421) | 2.20666535 |
79 | Myopathic facies (HP:0002058) | 2.20277317 |
80 | Orchitis (HP:0100796) | 2.19677284 |
81 | Abnormal hemoglobin (HP:0011902) | 2.17779825 |
82 | Mucopolysacchariduria (HP:0008155) | 2.16109074 |
83 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.16109074 |
84 | Severe visual impairment (HP:0001141) | 2.15092551 |
85 | Eosinophilia (HP:0001880) | 2.14614887 |
86 | Increased variability in muscle fiber diameter (HP:0003557) | 2.14338058 |
87 | Vasculitis (HP:0002633) | 2.13979538 |
88 | Emphysema (HP:0002097) | 2.13944087 |
89 | Mutism (HP:0002300) | 2.13096727 |
90 | Viral hepatitis (HP:0006562) | 2.12936544 |
91 | Abnormality of the nasal mucosa (HP:0000433) | 2.12300263 |
92 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.11491863 |
93 | Abnormality of B cell number (HP:0010975) | 2.10855802 |
94 | B lymphocytopenia (HP:0010976) | 2.10855802 |
95 | Nonimmune hydrops fetalis (HP:0001790) | 2.10044270 |
96 | Increased connective tissue (HP:0009025) | 2.09152010 |
97 | Arterial thrombosis (HP:0004420) | 2.08175880 |
98 | Increased serum ferritin (HP:0003281) | 2.04161861 |
99 | Arterial tortuosity (HP:0005116) | 2.03589052 |
100 | Muscle stiffness (HP:0003552) | 2.03434047 |
101 | Bulbar palsy (HP:0001283) | 2.02195445 |
102 | Cerebral aneurysm (HP:0004944) | 2.01777259 |
103 | Diminished motivation (HP:0000745) | 2.01585882 |
104 | Lymphoma (HP:0002665) | 2.01516543 |
105 | Broad face (HP:0000283) | 2.01496231 |
106 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.01226135 |
107 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.01226135 |
108 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.01226135 |
109 | Leukocytosis (HP:0001974) | 2.01027862 |
110 | Premature rupture of membranes (HP:0001788) | 2.00806585 |
111 | Abnormality of reticulocytes (HP:0004312) | 1.99218564 |
112 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.98795356 |
113 | Hypertriglyceridemia (HP:0002155) | 1.97503170 |
114 | Nasal polyposis (HP:0100582) | 1.97205359 |
115 | Hemoptysis (HP:0002105) | 1.97051628 |
116 | Progressive muscle weakness (HP:0003323) | 1.96098981 |
117 | IgA deficiency (HP:0002720) | 1.95282127 |
118 | Lymphopenia (HP:0001888) | 1.95262990 |
119 | Increased density of long bones (HP:0006392) | 1.94841502 |
120 | Verrucae (HP:0200043) | 1.94754035 |
121 | Papilloma (HP:0012740) | 1.94754035 |
122 | Abnormal number of erythroid precursors (HP:0012131) | 1.94458535 |
123 | Spinal cord lesions (HP:0100561) | 1.93208171 |
124 | Syringomyelia (HP:0003396) | 1.93208171 |
125 | Purpura (HP:0000979) | 1.92666938 |
126 | Hepatosplenomegaly (HP:0001433) | 1.92397027 |
127 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.92231827 |
128 | Pulmonary infiltrates (HP:0002113) | 1.92123682 |
129 | Amaurosis fugax (HP:0100576) | 1.89983883 |
130 | Recurrent lower respiratory tract infections (HP:0002783) | 1.89420961 |
131 | Deformed sella turcica (HP:0002681) | 1.89291964 |
132 | Gingivitis (HP:0000230) | 1.89242302 |
133 | Gastrointestinal stroma tumor (HP:0100723) | 1.88871898 |
134 | Spondylolisthesis (HP:0003302) | 1.88692759 |
135 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.88078327 |
136 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.87926567 |
137 | Aortic aneurysm (HP:0004942) | 1.87834930 |
138 | Agnosia (HP:0010524) | 1.85892293 |
139 | Systemic lupus erythematosus (HP:0002725) | 1.84615359 |
140 | Upper motor neuron abnormality (HP:0002127) | 1.84512536 |
141 | Polygenic inheritance (HP:0010982) | 1.84087753 |
142 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.83884319 |
143 | Increased IgE level (HP:0003212) | 1.83452957 |
144 | Epistaxis (HP:0000421) | 1.83073092 |
145 | Apathy (HP:0000741) | 1.81903412 |
146 | Neoplasm of head and neck (HP:0012288) | 1.81630490 |
147 | Esophageal neoplasm (HP:0100751) | 1.81630490 |
148 | Optic neuritis (HP:0100653) | 1.81430079 |
149 | Retrobulbar optic neuritis (HP:0100654) | 1.81430079 |
150 | Osteomyelitis (HP:0002754) | 1.81365667 |
151 | Achilles tendon contracture (HP:0001771) | 1.81338918 |
152 | Paralysis (HP:0003470) | 1.78161359 |
153 | Distal lower limb amyotrophy (HP:0008944) | 1.78063240 |
154 | Cervical subluxation (HP:0003308) | 1.77755840 |
155 | Myocardial infarction (HP:0001658) | 1.77477569 |
156 | Poikilocytosis (HP:0004447) | 1.77470326 |
157 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.76841754 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.13514342 |
2 | SMG1 | 3.95021487 |
3 | TGFBR2 | 3.05278305 |
4 | VRK2 | 2.96883224 |
5 | PIM2 | 2.96003763 |
6 | BLK | 2.74483881 |
7 | TBK1 | 2.39225749 |
8 | NME2 | 2.38865981 |
9 | KIT | 2.36966273 |
10 | ZAP70 | 2.33904758 |
11 | JAK3 | 2.32892687 |
12 | EEF2K | 2.32353013 |
13 | ERN1 | 2.30502417 |
14 | PKN2 | 2.21587547 |
15 | TAOK2 | 2.20745778 |
16 | TYK2 | 2.14906866 |
17 | TRIB3 | 2.02406219 |
18 | TXK | 1.87809275 |
19 | IRAK3 | 1.80606997 |
20 | RIPK4 | 1.77093266 |
21 | MAP2K3 | 1.75120132 |
22 | SCYL2 | 1.73142232 |
23 | CLK1 | 1.60407859 |
24 | BTK | 1.58415321 |
25 | CSF1R | 1.58176568 |
26 | ICK | 1.55523370 |
27 | SIK1 | 1.54431691 |
28 | KDR | 1.53995084 |
29 | MAP3K14 | 1.51444794 |
30 | TEC | 1.49570184 |
31 | IKBKB | 1.47141091 |
32 | TSSK6 | 1.46822641 |
33 | STK10 | 1.43273807 |
34 | MAP3K11 | 1.42048152 |
35 | SYK | 1.41567582 |
36 | FES | 1.41525886 |
37 | TAF1 | 1.35183240 |
38 | RPS6KA4 | 1.32197094 |
39 | TESK2 | 1.31345376 |
40 | CAMKK2 | 1.30078634 |
41 | IRAK4 | 1.23576173 |
42 | IKBKE | 1.22343654 |
43 | LRRK2 | 1.22218214 |
44 | HCK | 1.17667871 |
45 | NEK1 | 1.13119715 |
46 | RAF1 | 1.12741055 |
47 | MAP3K10 | 1.12702353 |
48 | EPHB1 | 1.08887553 |
49 | MAPK11 | 1.08403791 |
50 | FLT3 | 1.06740894 |
51 | PRKD2 | 1.02051162 |
52 | LYN | 1.01597529 |
53 | JAK1 | 1.00879099 |
54 | LCK | 1.00869803 |
55 | TGFBR1 | 0.97544258 |
56 | IRAK2 | 0.95737526 |
57 | MOS | 0.95458831 |
58 | TESK1 | 0.93084641 |
59 | EIF2AK3 | 0.91982753 |
60 | BMX | 0.90616279 |
61 | MAP3K5 | 0.89371496 |
62 | ITK | 0.89220930 |
63 | PIM1 | 0.88938594 |
64 | TTN | 0.88712459 |
65 | ABL2 | 0.85089215 |
66 | PAK4 | 0.84848026 |
67 | RPS6KB2 | 0.82410471 |
68 | PRKD3 | 0.81725041 |
69 | CHUK | 0.79731969 |
70 | MAPKAPK3 | 0.79563876 |
71 | PAK2 | 0.77594551 |
72 | PRKG2 | 0.77280356 |
73 | CSK | 0.76417369 |
74 | MAP3K8 | 0.75859161 |
75 | CDK8 | 0.73254372 |
76 | ARAF | 0.72595869 |
77 | CDC42BPA | 0.72155258 |
78 | SIK3 | 0.71104364 |
79 | KSR2 | 0.70964876 |
80 | STK4 | 0.69848240 |
81 | ILK | 0.68265002 |
82 | DDR2 | 0.67925835 |
83 | BRAF | 0.67525950 |
84 | JAK2 | 0.64450919 |
85 | GRK7 | 0.63916039 |
86 | PDGFRA | 0.63905932 |
87 | MAP3K13 | 0.63859973 |
88 | BCKDK | 0.61087768 |
89 | PTK2 | 0.60591929 |
90 | WEE1 | 0.59739791 |
91 | STK16 | 0.58403966 |
92 | DAPK1 | 0.57943064 |
93 | MELK | 0.57941135 |
94 | RIPK1 | 0.57391137 |
95 | PDPK1 | 0.57269100 |
96 | CAMKK1 | 0.57026516 |
97 | MARK2 | 0.56886116 |
98 | FGFR4 | 0.56640755 |
99 | FGR | 0.56532335 |
100 | MATK | 0.56395930 |
101 | DAPK3 | 0.55404790 |
102 | BUB1 | 0.54662361 |
103 | NME1 | 0.53555843 |
104 | CDK9 | 0.53270783 |
105 | TAOK1 | 0.52774727 |
106 | CDK4 | 0.51031417 |
107 | CDK7 | 0.48633464 |
108 | HIPK2 | 0.47863624 |
109 | MAP3K3 | 0.47578475 |
110 | SIK2 | 0.46763981 |
111 | MAPKAPK2 | 0.46223282 |
112 | TIE1 | 0.46129937 |
113 | RPS6KA6 | 0.45088448 |
114 | RPS6KA2 | 0.44780079 |
115 | MTOR | 0.43381073 |
116 | NEK2 | 0.43197595 |
117 | EPHA2 | 0.42986952 |
118 | ATR | 0.41000458 |
119 | MARK3 | 0.40353088 |
120 | MAP2K2 | 0.40218257 |
121 | VRK1 | 0.39936960 |
122 | PTK2B | 0.39875053 |
123 | ALK | 0.39358464 |
124 | RPS6KC1 | 0.39300301 |
125 | RPS6KL1 | 0.39300301 |
126 | MAPK12 | 0.38169917 |
127 | EIF2AK2 | 0.38158503 |
128 | EIF2AK1 | 0.37291000 |
129 | GRK6 | 0.36982537 |
130 | PAK1 | 0.35058768 |
131 | PTK6 | 0.34556456 |
132 | ABL1 | 0.33704724 |
133 | NEK9 | 0.33305479 |
134 | TNK2 | 0.31818277 |
135 | MAP3K7 | 0.31272314 |
136 | MAP3K1 | 0.31204304 |
137 | PRPF4B | 0.30755393 |
138 | STK24 | 0.29654193 |
139 | FGFR3 | 0.28963152 |
140 | EGFR | 0.28282794 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.82769008 |
2 | Sulfur relay system_Homo sapiens_hsa04122 | 2.18747259 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.15922259 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.95856872 |
5 | DNA replication_Homo sapiens_hsa03030 | 1.95108428 |
6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.89503523 |
7 | * Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.85921681 |
8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.77439888 |
9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.74631520 |
10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.72823477 |
11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.71743421 |
12 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.71351844 |
13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.70097801 |
14 | Measles_Homo sapiens_hsa05162 | 1.69457168 |
15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.66279782 |
16 | Bladder cancer_Homo sapiens_hsa05219 | 1.59170187 |
17 | Legionellosis_Homo sapiens_hsa05134 | 1.59118393 |
18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.55891692 |
19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54259408 |
20 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.53087787 |
21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.49485824 |
22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.44779858 |
23 | Lysosome_Homo sapiens_hsa04142 | 1.42334741 |
24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.41335358 |
25 | Ribosome_Homo sapiens_hsa03010 | 1.39225591 |
26 | Proteasome_Homo sapiens_hsa03050 | 1.37665557 |
27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.36835833 |
28 | Shigellosis_Homo sapiens_hsa05131 | 1.35169137 |
29 | Allograft rejection_Homo sapiens_hsa05330 | 1.31988217 |
30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.29071165 |
31 | Tuberculosis_Homo sapiens_hsa05152 | 1.26232808 |
32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.26097241 |
33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.24927315 |
34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.23933957 |
35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.22374662 |
36 | Hepatitis B_Homo sapiens_hsa05161 | 1.22350221 |
37 | Base excision repair_Homo sapiens_hsa03410 | 1.21513702 |
38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21263206 |
39 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.20520207 |
40 | Apoptosis_Homo sapiens_hsa04210 | 1.20473947 |
41 | Influenza A_Homo sapiens_hsa05164 | 1.17841386 |
42 | Pertussis_Homo sapiens_hsa05133 | 1.17372092 |
43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16518855 |
44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15791376 |
45 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.15762406 |
46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13849599 |
47 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.13103310 |
48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.11957804 |
49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.11568267 |
50 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.09953473 |
51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08372320 |
52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.08136516 |
53 | Malaria_Homo sapiens_hsa05144 | 1.07358688 |
54 | Spliceosome_Homo sapiens_hsa03040 | 1.05844431 |
55 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.05061064 |
56 | Salmonella infection_Homo sapiens_hsa05132 | 1.04399400 |
57 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.00614802 |
58 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.00261163 |
59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.99718039 |
60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.95582780 |
61 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.94066447 |
62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.93662643 |
63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.93391743 |
64 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.92635275 |
65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90425091 |
66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90098796 |
67 | Carbon metabolism_Homo sapiens_hsa01200 | 0.89685666 |
68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.88135626 |
69 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85229103 |
70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85043229 |
71 | Asthma_Homo sapiens_hsa05310 | 0.84364237 |
72 | Mismatch repair_Homo sapiens_hsa03430 | 0.84046097 |
73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.83572290 |
74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83468821 |
75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.83077272 |
76 | Platelet activation_Homo sapiens_hsa04611 | 0.82419205 |
77 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81546102 |
78 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.81480425 |
79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81320475 |
80 | RNA transport_Homo sapiens_hsa03013 | 0.77516032 |
81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75330503 |
82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.73482677 |
83 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.70697111 |
84 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.70575632 |
85 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.70386283 |
86 | RNA polymerase_Homo sapiens_hsa03020 | 0.70194629 |
87 | Thyroid cancer_Homo sapiens_hsa05216 | 0.70167950 |
88 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69289233 |
89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.67156048 |
90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66012089 |
91 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65508797 |
92 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64866958 |
93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63985296 |
94 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.62637258 |
95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60940720 |
96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59814120 |
97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59775682 |
98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59425632 |
99 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58989762 |
100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58144804 |
101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57742513 |
102 | Prion diseases_Homo sapiens_hsa05020 | 0.57232209 |
103 | Phagosome_Homo sapiens_hsa04145 | 0.57141851 |
104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56967228 |
105 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.56468104 |
106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56369049 |
107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55288411 |
108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53681228 |
109 | Glioma_Homo sapiens_hsa05214 | 0.53217313 |
110 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53157027 |
111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52701214 |
112 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50938444 |
113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50430539 |
114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.49966057 |
115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49949466 |
116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49603968 |
117 | RNA degradation_Homo sapiens_hsa03018 | 0.49078961 |
118 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.48109865 |
119 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.47971342 |
120 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47133945 |
121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46884481 |
122 | Cell cycle_Homo sapiens_hsa04110 | 0.46763667 |
123 | Homologous recombination_Homo sapiens_hsa03440 | 0.46145334 |
124 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45888069 |
125 | Endocytosis_Homo sapiens_hsa04144 | 0.45140586 |
126 | Hepatitis C_Homo sapiens_hsa05160 | 0.44058840 |
127 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40207717 |